To test whether a short FD protocol can be used to test whether effects of light on alertness, sleep, metabolism and temperature are under circadian control.
ID
Source
Brief title
Condition
- Other condition
Synonym
Health condition
biologische klok, alertheid, slaperigheid, metabolisme
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameters are melatonin rhythms (saliva samples) and core body
temperature (CBT) to test whether a short FD protocol can be used as an
alternative to a multiple-week FD protocol in disentangling homeostatic and
circadian components affecting alertness, sleep, heart rate, metabolism and
body temperature.
Secondary outcome
Secondary study parameters are subjective sleepiness, subjective and objective
sleep quality, metabolic rate, heart rate, core body temperature and skin
temperature, to investigate whether light can affect alertness (and whether
this effect depends on the circadian clock).
Background summary
The forced desynchrony (FD) protocol is a common method in chronobiology to
disentangle homeostatic (e.g. sleep pressure buildup during waking and
dissipation during sleep) and circadian-clock (e.g. 24-hour rhythmicity in
sleepiness) related effects on rhythmic behavioral or physiological processes.
Such protocols typically involve the observation of participants in the
laboratory over multiple weeks under dim light (~5 lux) conditions. We want to
perform a pilot study to obtain an indication of whether the FD protocol can
also be performed under bright light conditions to test whether the effect of
light on output parameters (e.g. alertness, sleep, heart rate, metabolism and
core body temperature) is under circadian control. In addition, we are
interested to test whether an FD of 3 days can be used to disentangle
homeostatic and circadian components affecting the rhythmicity of these output
parameters. In the future, such short FD protocols will decrease the burden
experienced by participants when disentangling clock- and homeostatic related
factors impacting rhythmicity of physiological and behavioural processes.
Additionally, this pilot is crucial in knowing whether a short FD protocol
under bright light can be used to study clock-related effects of light on many
rhythmic processes.
Study objective
To test whether a short FD protocol can be used to test whether effects of
light on alertness, sleep, metabolism and temperature are under circadian
control.
Study design
This study will involve one 3-day FD protocol preceded and followed by 1
clock-phase assessment (dim-light melatonin onset). Light intensity during
wakefulness in the FD will be 5 lux. Three weeks later the same procedure will
be repeated, with an FD where light intensity levels of 1500 lux during
wakefulness are used. A separate group of individuals will perform both
procedures in reversed order.
Intervention
2 3-day FD protocols separated by a 3-week rehabilitation period
Study burden and risks
Subjects will remain for 4 days and 5 nights in the human isolation facility of
the University of Groningen. They will remain here under an alternative
day-night cycle (13 hours awake, 5 hours sleep). Multiple saliva samples will
be taken and in addition, subjects will fill in questionnaires and perform
reaction time tasks. Body temperature, heart rate, metabolism and brain
activity will also be measured.
Preceding the laboratory part and inbetween the laboratory parts, subjects will
wear a watch, which registers activity and light exposure profiles.
Nijenborgh 7
Groningen 9747 AG
NL
Nijenborgh 7
Groningen 9747 AG
NL
Listed location countries
Age
Inclusion criteria
Gezonde mannelijk proefpersonen
Leeftijd: 20-30
Schriftelijke ondertekening van het toestemmingsformulier
Exclusion criteria
Colour blindness
Sleeping problems
Usage of (recreational) drugs
Smoking
Moderate to high levels of caffeine intake
Diabetic disease
Shift work scheduled 3 months prior to participation
Travel over 2 or more time zones prior to participation
PSQI>5
Epworth Sleepiness Scale >10
Glasses
Use of photosensitizing medication or sleep medication
Use of melatonin
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
Other | 201700767 |
CCMO | NL63828.042.17 |